The role of RANK-ligand inhibition in cancer: the story of denosumab. [electronic resource]
Producer: 20110614Description: 136-45 p. digitalISSN:- 1549-490X
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- therapeutic use
- Bone Neoplasms -- drug therapy
- Bone Remodeling -- drug effects
- Breast Neoplasms -- pathology
- Clinical Trials as Topic
- Denosumab
- Humans
- Male
- Multiple Myeloma -- pathology
- Osteoclasts -- drug effects
- Prostatic Neoplasms -- pathology
- RANK Ligand -- antagonists & inhibitors
- Receptor Activator of Nuclear Factor-kappa B -- metabolism
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.